BioSyent Releases Results for Q1 2019
29 mai 2019 08h00 HE
|
BioSyent Inc.
TORONTO, May 29, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three months ended March 31, 2019. Key highlights...
BioSyent Schedules Q1 2019 Earnings Release for May 29, 2019
21 mai 2019 08h00 HE
|
BioSyent Inc.
TORONTO, May 21, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2019 on Wednesday,...
BioSyent Announces Health Canada Approval of New Women’s Health Product
13 mai 2019 16h01 HE
|
BioSyent Inc.
TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) announces that Health Canada has approved Tibella® (tibolone), indicated for the short-term...
BioSyent Releases Results for Fourth Quarter and Full Year 2018
20 mars 2019 08h00 HE
|
BioSyent Inc.
TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and twelve months ended December 31, 2018. Key...
BioSyent Announces Normal Course Issuer Bid
04 déc. 2018 08h00 HE
|
BioSyent Inc.
TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the Company’s Notice...
BioSyent Releases Results for Third Quarter and First Nine Months of 2018
21 nov. 2018 08h00 HE
|
BioSyent Inc.
TORONTO, Nov. 21, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and nine months ended September 30, 2018. Key...
BioSyent Named to the Growth 500 Ranking of Canada's Fastest-Growing Companies for Sixth Consecutive Year
13 sept. 2018 09h00 HE
|
BioSyent Inc.
TORONTO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it has been named to the annual Growth 500 ranking of Canada’s Fastest-Growing...
BioSyent Announces Changes to Executive Management
10 sept. 2018 17h28 HE
|
BioSyent Inc.
TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) today announced changes to its Executive Management team: Effective on September 10, 2018, Mr....
BioSyent to Present at Upcoming Investor Conference
24 août 2018 12h00 HE
|
BioSyent Inc.
TORONTO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”) (TSX Venture: RX) is pleased to announce that it will be presenting at the Midwest IDEAS Investor Conference at...
BioSyent Schedules Q1 2018 Earnings Release for May 30, 2018
17 mai 2018 08h00 HE
|
BioSyent Inc.
TORONTO, May 17, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”) (TSX Venture:RX) will be reporting its financial results for the first quarter ended March 31, 2018 on Wednesday,...